Deutsche Bank analyst Krisztina Katai maintains Kroger (NYSE:KR) with a Hold and lowers the price target from $56 to $55.
Verastem Oncology Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Terms Disclosed
Verastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and pre-funded
